> top > docs > PMC:7536947 > annotations

PMC:7536947 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T1 659-663 Body_part denotes Skin http://purl.org/sig/ont/fma/fma7163
T2 1292-1296 Body_part denotes Skin http://purl.org/sig/ont/fma/fma7163

LitCovid-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T1 659-663 Body_part denotes Skin http://purl.obolibrary.org/obo/UBERON_0000014
T2 1292-1296 Body_part denotes Skin http://purl.obolibrary.org/obo/UBERON_0000014

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T1 14-23 Disease denotes Urticaria http://purl.obolibrary.org/obo/MONDO_0005492
T2 27-35 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T3 135-143 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T4 293-302 Disease denotes urticaria http://purl.obolibrary.org/obo/MONDO_0005492
T5 591-599 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T6 618-622 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T7 632-641 Disease denotes Urticaria http://purl.obolibrary.org/obo/MONDO_0005492
T8 645-655 Disease denotes Angioedema http://purl.obolibrary.org/obo/MONDO_0010481
T9 659-668 Disease denotes Skin rash http://purl.obolibrary.org/obo/MONDO_0006547
T10 751-760 Disease denotes urticaria http://purl.obolibrary.org/obo/MONDO_0005492
T11 768-778 Disease denotes angioedema http://purl.obolibrary.org/obo/MONDO_0010481
T12 786-794 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T13 795-804 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T14 1046-1055 Disease denotes urticaria http://purl.obolibrary.org/obo/MONDO_0005492
T15 1063-1073 Disease denotes angioedema http://purl.obolibrary.org/obo/MONDO_0010481
T16 1078-1086 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T17 1087-1096 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T18 1201-1210 Disease denotes urticaria http://purl.obolibrary.org/obo/MONDO_0005492
T19 1450-1459 Disease denotes urticaria http://purl.obolibrary.org/obo/MONDO_0005492
T20 1538-1546 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T21 1731-1739 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T1 46-47 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T2 104-114 http://purl.obolibrary.org/obo/BFO_0000030 denotes Objectives
T3 144-147 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T4 444-445 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T5 659-663 http://purl.obolibrary.org/obo/UBERON_0000014 denotes Skin
T6 659-663 http://purl.obolibrary.org/obo/UBERON_0001003 denotes Skin
T7 659-663 http://purl.obolibrary.org/obo/UBERON_0002097 denotes Skin
T8 659-663 http://purl.obolibrary.org/obo/UBERON_0002199 denotes Skin
T9 659-663 http://www.ebi.ac.uk/efo/EFO_0000962 denotes Skin
T10 1292-1296 http://purl.obolibrary.org/obo/UBERON_0000014 denotes Skin
T11 1292-1296 http://purl.obolibrary.org/obo/UBERON_0001003 denotes Skin
T12 1292-1296 http://purl.obolibrary.org/obo/UBERON_0002097 denotes Skin
T13 1292-1296 http://purl.obolibrary.org/obo/UBERON_0002199 denotes Skin
T14 1292-1296 http://www.ebi.ac.uk/efo/EFO_0000962 denotes Skin

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T1 1380-1394 Chemical denotes antihistamines http://purl.obolibrary.org/obo/CHEBI_37956
T2 1402-1410 Chemical denotes steroids http://purl.obolibrary.org/obo/CHEBI_35341
T3 1487-1495 Chemical denotes steroids http://purl.obolibrary.org/obo/CHEBI_35341
T4 1571-1585 Chemical denotes antihistamines http://purl.obolibrary.org/obo/CHEBI_37956
T5 1596-1608 Chemical denotes prednisolone http://purl.obolibrary.org/obo/CHEBI_8378

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
3 36-44 Species denotes Patients Tax:9606
4 14-23 Disease denotes Urticaria MESH:D014581
5 27-35 Disease denotes COVID‐19 MESH:C000657245
10 271-279 Species denotes patients Tax:9606
11 135-143 Disease denotes COVID‐19 MESH:C000657245
12 190-199 Disease denotes mortality MESH:D003643
13 293-302 Disease denotes urticaria MESH:D014581
23 591-614 Species denotes COVID‐19,” “Coronavirus Tax:2697049
24 618-628 Species denotes SARS‐Cov‐2 Tax:2697049
25 632-641 Disease denotes Urticaria MESH:D014581
26 645-655 Disease denotes Angioedema MESH:D000799
27 659-668 Disease denotes Skin rash MESH:D005076
28 751-760 Disease denotes urticaria MESH:D014581
29 768-778 Disease denotes angioedema MESH:D000799
30 786-794 Disease denotes COVID‐19 MESH:C000657245
31 795-804 Disease denotes infection MESH:D007239
43 1032-1040 Species denotes patients Tax:9606
44 1147-1155 Species denotes patients Tax:9606
45 1402-1410 Chemical denotes steroids MESH:D013256
46 1487-1495 Chemical denotes steroids MESH:D013256
47 1046-1055 Disease denotes urticaria MESH:D014581
48 1063-1073 Disease denotes angioedema MESH:D000799
49 1078-1086 Disease denotes COVID‐19 MESH:C000657245
50 1087-1096 Disease denotes infection MESH:D007239
51 1201-1210 Disease denotes urticaria MESH:D014581
52 1292-1304 Disease denotes Skin lesions MESH:D012871
53 1450-1459 Disease denotes urticaria MESH:D014581
59 1547-1555 Species denotes patients Tax:9606
60 1786-1794 Species denotes patients Tax:9606
61 1596-1608 Chemical denotes prednisolone MESH:D011239
62 1538-1546 Disease denotes COVID‐19 MESH:C000657245
63 1731-1739 Disease denotes COVID‐19 MESH:C000657245

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T1 14-23 Phenotype denotes Urticaria http://purl.obolibrary.org/obo/HP_0001025
T2 293-302 Phenotype denotes urticaria http://purl.obolibrary.org/obo/HP_0001025
T3 632-641 Phenotype denotes Urticaria http://purl.obolibrary.org/obo/HP_0001025
T4 645-655 Phenotype denotes Angioedema http://purl.obolibrary.org/obo/HP_0100665
T5 659-668 Phenotype denotes Skin rash http://purl.obolibrary.org/obo/HP_0000988
T6 751-760 Phenotype denotes urticaria http://purl.obolibrary.org/obo/HP_0001025
T7 768-778 Phenotype denotes angioedema http://purl.obolibrary.org/obo/HP_0100665
T8 1046-1055 Phenotype denotes urticaria http://purl.obolibrary.org/obo/HP_0001025
T9 1063-1073 Phenotype denotes angioedema http://purl.obolibrary.org/obo/HP_0100665
T10 1201-1210 Phenotype denotes urticaria http://purl.obolibrary.org/obo/HP_0001025
T11 1450-1459 Phenotype denotes urticaria http://purl.obolibrary.org/obo/HP_0001025

LitCovid-PD-GO-BP

Id Subject Object Predicate Lexical cue
T1 1715-1727 http://purl.obolibrary.org/obo/GO_0009405 denotes pathogenesis

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T1 0-45 Sentence denotes Management of Urticaria in COVID‐19 Patients:
T2 46-65 Sentence denotes A Systematic Review
T3 66-83 Sentence denotes Abuelgasim et al.
T4 85-93 Sentence denotes Abstract
T5 94-102 Sentence denotes Abstract
T6 104-114 Sentence denotes Objectives
T7 115-233 Sentence denotes The global pandemic COVID‐19 has resulted in significant global morbidity, mortality and increased healthcare demands.
T8 234-303 Sentence denotes There is now emerging evidence in of patients experiencing urticaria.
T9 304-406 Sentence denotes We sought to systematically review current evidence, critique the literature and present out findings.
T10 408-415 Sentence denotes Methods
T11 416-692 Sentence denotes Allowing PRISMA guidelines, a comprehensive literature search was carried out with Medline, EMBASE, Scopus, Cochrane, and Google Scholar, using key MeSH words, which include “COVID‐19,” “Coronavirus”, “SARS‐Cov‐2”, “Urticaria,” “Angioedema,” “Skin rash” up to August, 01 2020.
T12 693-841 Sentence denotes The key inclusion criteria were articles that reported on urticaria and/or angioedema due to COVID‐19 infection and reported management and outcome.
T13 842-908 Sentence denotes Studies were excluded if no case or cohort outcomes were observed.
T14 910-917 Sentence denotes Results
T15 918-987 Sentence denotes Our search returned 169 articles, 25 of which met inclusion criteria.
T16 988-1134 Sentence denotes All studies were case reports, reporting 26 patients with urticaria and/or angioedema and COVID‐19 infection and their management and/or response.
T17 1135-1191 Sentence denotes Majority of patients (n=16, 69%) were over 50 years old.
T18 1192-1291 Sentence denotes However, urticaria in the younger ages was not uncommon, with reported case of 2 months old infant.
T19 1292-1411 Sentence denotes Skin lesions resolved from less than 24 hours to up to 2 weeks following treatment with antihistamines and/or steroids.
T20 1412-1496 Sentence denotes There have been no cases of recurrent urticaria or cases non‐responsive to steroids.
T21 1498-1509 Sentence denotes Conclusions
T22 1510-1586 Sentence denotes Management of urticarial in COVID‐19 patients should involve antihistamines.
T23 1587-1657 Sentence denotes Low dose prednisolone should be considered on an individualised basis.
T24 1658-1740 Sentence denotes Further research is required in understanding urticarial pathogenesis in COVID‐19.
T25 1741-1869 Sentence denotes This will aid early diagnostic assessment in patients with high index of suspicion and subsequent management in the acute phase.
T26 1870-1909 Sentence denotes This article is protected by copyright.
T27 1910-1930 Sentence denotes All rights reserved.